Skip to main content

Table 3 Comparison of responses before and after the training on pharmacovigilance regarding knowledge and attitude related questions

From: Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital

Knowledge related questions Healthcare professionals (n, %) p-value
Pre-survey correct response (n, %) Post-survey correct response (n, %)
Adverse Drug Reaction (ADR) definition 56 (62.9) 89 (100) < 0.001
Pharmacovigilance (PV) definition 56 (62.9) 84 (94.4) < 0.001
Most important purpose of Pharmacovigilance 47 (52.8) 86 (96.6) < 0.001
A serious adverse event in Nepal that should be reported to a regulatory body within 20 (22.5) 79 (88.8) < 0.001
Rare Adverse Drug Reactions can be identified in the following phase of the clinical trial 32 (36) 78 (87.6) < 0.001
Which of the following methods is commonly employed by pharmaceutical companies to monitor? 55 (61.8) 79 (88.8) < 0.001
Do you think ADR reporting is professional responsibility for you 78 (87.6) 89 (100) < 0.001
The healthcare professionals responsible for reporting ADR in a hospital is/are 82 (92.1) 87 (97.8) < 0.001
Do you know about the existence of a National PV program in Nepal 39 (43.8) 88 (98.9) < 0.001
In Nepal, which regulatory body is responsible for monitoring ADR 39 (4.8) 82 (96.1) < 0.001
Where the international center for ADR monitoring is located 40 (44.9) 86 (96.6) < 0.001
One of the following agencies in the USA involved in drug safety issues 50 (56.2) 84 (94.4) < 0.001
Attitude related statements Pre-Survey Agreement (n, %) Post-Survey Agreement (n, %) p-value
Reporting of ADRs as the exploration of mistakes of health professionals 21 (23.6%) 59 (66.3%) < 0.001
Reporting of adverse drug reaction is necessary 31 (34.8%) 89 (100%) < 0.001
Establishing ADR monitoring center in every hospital 69 (77.5%) 84 (94.4%) 0.001
Reporting ADR will increase patient safety 39 (43.8%) 89 (100%) < 0.001